Health Economic Evaluation of costs and benefits of a computer based program called Deprexis used for insured persons of the DAK (statutory health insurance) suffering from depressio

Not Applicable

• Conditions: F32.0; F32.1; Mild depressive episode; Moderate depressive episode

• Registration Number: DRKS00003564
• Lead Sponsor: D A K - GesundheitUnternehmen LebenVorstandsreferat Versorgungsforschung (0010 30)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-02-17
• Study Completion: 2014-05-19
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 3832

Inclusion Criteria

(a) At least a mild depression: PHQ-9 >= 5
(b) age of at least 18 years
(c) Informed Consent
(d) Insured by the DAK at least for one year and availabilty of costs one year before and one year after the treatment with Deprexis
(e) Access to the internet

Exclusion Criteria

Danger of suizidal tendencies; measured by item number 9 of the questionnaire PHQ-9 (value > 0)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
costs, that occured in a period of one year after the end of treatment determined by the DAK (Statutory Health Insurance)

Secondary Outcome Measures

Name	Time	Method
Quality of life measured by the SF12 and the EQ-5D at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The severity of depression: by the PHQ-9 at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3). The social functioning: measured by the WSAS at the beginning (T0), after 12 weeks (T1), after 6 months (T2) and after 12 months (T3).